Abstract
The average molecular mass of β-glucan was 241,700 g/mol with a polydispersity of 1.433. At lower concentrations, gels showed Newtonian flow behaviour and shear thinning properties at higher concentrations. There was no effect of pH on the flow properties of the β-glucans at lower concentrations of 1% while at higher concentrations of 4% and above viscosity increased with pH 4 or greater. A progressive decrease in viscosity with increasing temperature for all concentrations of samples tested at a constant shear rate was observed. A set gel structure was not formed below 3% β-glucan so 2% solutions were used to incorporate lactoferrin at room temperature prior to film casting and cryomilling to prepare microparticles. There was an initial burst lactoferrin release from all microparticles, with final amount released after 7 hours only 35 and 32 % for β-glucan alone or with the addition of PEG 2000 respectively. Final lactoferrin release after 7 hours was 91% when Kolicoat was added to the formulation. Stress studies on β-glucan indicated that there was no degradation of the β-glucan at gastric conditions of low pH, which suggests that β-glucan might protect fragile molecules under gastric conditions.
Keywords: Barley β-glucan, lactoferrin, microparticle, release assessment, texture analysis, viscosity.
Current Drug Delivery
Title:Physiochemical Characterization of β-glucan and in vitro Release of Lactoferrin from β-glucan Microparticles
Volume: 10 Issue: 6
Author(s): Hemant Kumar, Jinguyan Wen, John Shaw, Jillian Cornish and Craig Bunt
Affiliation:
Keywords: Barley β-glucan, lactoferrin, microparticle, release assessment, texture analysis, viscosity.
Abstract: The average molecular mass of β-glucan was 241,700 g/mol with a polydispersity of 1.433. At lower concentrations, gels showed Newtonian flow behaviour and shear thinning properties at higher concentrations. There was no effect of pH on the flow properties of the β-glucans at lower concentrations of 1% while at higher concentrations of 4% and above viscosity increased with pH 4 or greater. A progressive decrease in viscosity with increasing temperature for all concentrations of samples tested at a constant shear rate was observed. A set gel structure was not formed below 3% β-glucan so 2% solutions were used to incorporate lactoferrin at room temperature prior to film casting and cryomilling to prepare microparticles. There was an initial burst lactoferrin release from all microparticles, with final amount released after 7 hours only 35 and 32 % for β-glucan alone or with the addition of PEG 2000 respectively. Final lactoferrin release after 7 hours was 91% when Kolicoat was added to the formulation. Stress studies on β-glucan indicated that there was no degradation of the β-glucan at gastric conditions of low pH, which suggests that β-glucan might protect fragile molecules under gastric conditions.
Export Options
About this article
Cite this article as:
Kumar Hemant, Wen Jinguyan, Shaw John, Cornish Jillian and Bunt Craig, Physiochemical Characterization of β-glucan and in vitro Release of Lactoferrin from β-glucan Microparticles, Current Drug Delivery 2013; 10 (6) . https://dx.doi.org/10.2174/15672018113109990043
DOI https://dx.doi.org/10.2174/15672018113109990043 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers